Operator first. Advisor second.

Senior commercial leadership for life sciences companies that need execution to match ambition.

Anthony W. Luttenberger brings commercial leadership across pharmaceuticals, biotechnology, healthcare data, real-world evidence, patient access, commercialization, and executive GTM execution.

Anthony W. Luttenberger

Operating Context

Commercial leadership across complex healthcare markets.

Anthony's work spans healthcare data and technology, evidence development, safety and risk management, patient access services, product commercialization, real-world evidence, outcomes research, clinical trials, and commercial strategy.

The advisory focus is practical: align people, structure, strategy, and execution so revenue growth is managed through evidence rather than hope.

01

Execution Discipline

Commercial reviews that expose what changed, what is real, and what needs a decision.

02

Life Sciences Fluency

GTM planning that reflects evidence, access, regulatory, clinical, payer, provider, and adoption realities.

03

Outcome Orientation

Operating systems that connect customer value, commercial scale, retention, EBITDA, and enterprise value.

Focused conversation

Discuss the commercial constraint that matters most right now.

Discuss GTM Execution Risk